BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Ims2186

an antiangiogenic agent that acts against choroidal neovascularization; structure in first source Heading Mapped to: Chromones

1+ PubMed studies analyzed

Research Domains

Ims2186 has been studied across 2 research domains including 🔬 Oncology, ✨ Skin & Hair. The primary research focus is 🔬 Oncology with 100% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Ims2186, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Deslanoside
4 shared targets
Thapsigargin
4 shared targets
Phenylbutazone
4 shared targets
Proscillaridin
3 shared targets
Homoharringtonine
2 shared targets
Feprazone
3 shared targets
thiophanate
2 shared targets
Robenidine
2 shared targets
Furazolidone
2 shared targets
Warfarin
2 shared targets
Loading evidence profile...

This evidence profile for Ims2186 is generated deterministically from 1 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.